Impact of new potential treatments
Clinical trials are vital to determining the impact of new potential treatments, and only 12% of medicines in clinical trials make it to the patients. We are fully engaged in helping the biggest drug developers to develop novel medicines, ensuring the treatment moves through the first phase reaching the patients in need.
Cost-effective biologics
Biosimilars have significantly contributed to reducing costs for patients and healthcare systems, which is why many drug developers focus on biosimilar production. We have contributed to the development of numerous cost-effective biologics – we are prepared to use our knowledge and help you in their development.
Patient-centered environment
Patient-centric drug development is now becoming the model that the industry is following. We also followed the model and invested in creating a patient-centered environment to ensure our healthy volunteers and patients are well accommodated. As a result, our facilities meet the needs of the most demanding clients and patients.
A trusted and experienced partner
Our experts have an in-depth understanding of a variety of pharmaceutical indications – this allowed us to support over 1000 clinical studies for global sponsors. Biokinetica is an experienced partner that you can trust. Learn more about our offer on our website: https://en.biokinetica.com
Unique clinical trial recruitment strategies
The best clinical trial recruitment strategies start by focusing on the patient perspective. However, what makes us successful in searching for ideal subjects for you is our diverse approach. Thanks to our unique clinical trial recruitment strategies, we engage with different communities to help you reach a wide range of patients from diverse backgrounds.
Dedicated SARS-Cov-2 PCR testing facility
We will help you advance your research with our state-of-the-art, fully equipped in-house laboratory owning a separate dedicated SARS-Cov-2 PCR testing facility, as well as a modern biostorage area.
6,000 new volunteers joined our base
Patient recruitment timeframes are critical parts of clinical trials. With us, you can rest assured that your early phase clinical trials are delivered on time to the highest scientific standards. Thanks to our recruitment methods, our base of healthy volunteers is constantly growing – in the last 6 months, 6,000 new volunteers joined our base!
Chronic pain affects at least 10% of the world’s population
Chronic pain affects at least 10% of the world’s population – approximately 60 million people due to the complexity of pain still lack effective treatments for many pain disorders. Doctors worldwide call for the development of novel analgesics whose mechanisms do not involve the mu (μ) receptors. Thanks to the experience, Biokinetica is armed with […]
Improving patient engagement
The average dropout rate across all clinical trials is above 30% – but we aim to challenge this. We are committed to improving patient engagement through communication and maximising trial participants’ understanding. Our decisions always conform to the preferences of our patients and clients.
Breakthrough in cancer treatment?
Potential breakthrough in cancer treatment on the horizon? A radical new inhibitor of Myc (a protein implicated in the formation of most human cancers) has just entered the first-in-human phase I/II clinical trials. We are looking forward to the next novel cancer treatment benefiting patients in need.
